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Background
Protein Lysine methyltransferases (PKMTs) are group of
histone modifiers that are responsible for the transfer of
one to three methyl groups from S-adenosyl-L-methionine
(AdoMet) to the ε-amino group of the target lysine resi-
dues in histones[1] and some non-histone targets[2]. To
date more than 50 PKMTs have been identified and
EHMT1 (Euchromatic Histone Methyltransferase 1, GLP,
G9a like proteins) and EHMT2 (Euchromatic Histone
Methyltranferase 2, G9a) are amongst the most studied
ones. Genetic variations of EHMT1/2 have been associated
with human diseases such as cancer, inflammatory dis-
eases and neuro-generative disorders. As a consequence,
there has been a growing interest to identify potent inhibi-
tors of these enzymes.
Materials and methods
We employed Sinefungin as a lead structure for the design
and synthesis of a series of methyltransferase inhibitors
and tested them for inhibition of EHMT1/2. The a-amino
acid moiety of Sinefungin was exchanged to obtain two
different series of compounds- one with the additional
amino group and one without amino group. Screening of
compounds were done by using a FRET-based LANCE
ultra G9a histone H3-Lysine N-methyltransferase assay[3]
that measures the dimethylation of a biotinylated histone
H3 (1-21) peptide at lysine 9.
Results
A series of analogues of the natural product Sinefungin
was designed and synthesized, and probed for their ability
to inhibit EHMT1 and EHMT2. This led to a highly
potent inhibitor 4d with a Ki of 5 nM at EHMT1 and
24 nM at EHMT2. There was variation in the activity of
the compounds and most of the compounds displayed
little inhibition.
Conclusion
Here we exchanged the a-amino acid moiety and demon-
strated that it is not essential for inhibitory activity at
EHMT1/2. Our results indicate that these scaffolds upon
further modifications can lead to selective, potent inhibi-
tors of EHMTs and possibly other PKMTs.
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